Atlas Trials

Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults

Clinical trial NCT01811823 · COMPLETED

Trial details

NCT number
NCT01811823
Sponsor
University of Witwatersrand, South Africa
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
InfluenzaHIVTuberculosis
Start date
2014-03-31
Primary completion
2014-11-20
Enrollment
301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.